T细胞免疫受体单抗联合疗法于晚期肝细胞癌一线治疗中的应用与挑战：基于两项Ⅱ期临床研究结果的述评
江宁, 李旭初, 黄慧瑶, 孙超, 房虹, 马海兰, 贾硕鹏, 吴大维, 唐玉, 李宁
Combination therapy with TIGIT monoclonal antibody in the first-line treatment of advanced hepatocellular carcinoma: a commentary based on the results of two phase-Ⅱ clinical studies
Jiang Ning, Li Xuchu, Huang Huiyao, Sun Chao, Fang Hong, Ma Hailan, Jia Shuopeng, Wu Dawei, Tang Yu, Li Ning
肝癌电子杂志
.
2024, (4): 6
-12
.
